Home/KnolSights/Merger and Acquisitions/BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
June 12, 2025

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition

Abstract
Publication Reports